Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma

被引:81
作者
Jacobson, LP
Jenkins, FJ
Springer, G
Muñoz, A
Shah, KV
Phair, J
Zhang, ZF
Armenian, H
机构
[1] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[3] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA
[4] Univ Pittsburgh, Dept Microbiol, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Infect Dis, Pittsburgh, PA USA
[6] Northwestern Univ, Sch Med, Comprehens AIDS Ctr, Chicago, IL USA
[7] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA
关键词
D O I
10.1086/315503
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine Kaposi's sarcoma (KS) risk related to timing of human immunodeficiency virus type 1 (HIV-1) and human herpesvirus type 8 (HHV-8) infections, stored longitudinal sera from 400 homosexual men with known dates of HIV-1 seroconversion (+/- 4.5 months) were tested for HHV-8 antibody. Times from HHV-8 seroconversion to KS were compared for the 69 men who became infected with HHV-8 after acquiring HIV-1 to the 182 men who were HHV-8 seropositive before their HIV-1 infection. None developed KS before coinfection, HHV-8 seroconversion after HIV-1 infection increased the risk of KS (risk ratio, 2.55; 95% confidence interval, 1.06-6.10) compared with those infected with HHV-8 before HIV-1. The KS hazards in HHV-8 infected men increased by 60% (P < .001) for each year of HIV-1 infection. Faster CD4 cell loss and higher HIV-1 RNA levels significantly predicted KS. The quicker development of KS in men acquiring HHV-8 after HIV-1 and its association with CD4 slope argues that KS is more likely if HHV-8 infection occurs in an immunocompromised person.
引用
收藏
页码:1940 / 1949
页数:10
相关论文
共 70 条
[1]   ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN [J].
ALBINI, A ;
BARILLARI, G ;
BENELLI, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4838-4842
[2]  
[Anonymous], 1997, Viral Infections of Humans: Epidemiology and Control
[3]  
[Anonymous], 1992, J EPIDEMIOLOGY JAPAN
[4]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[5]   COMPOSITE RISK SCORE FOR KAPOSI-SARCOMA BASED ON A CASE-CONTROL AND LONGITUDINAL-STUDY IN THE MULTICENTER AIDS COHORT STUDY (MACS) POPULATION [J].
ARMENIAN, HK ;
HOOVER, DR ;
RUBB, S ;
METZ, S ;
KASLOW, R ;
VISSCHER, B ;
CHMIEL, J ;
KINGSLEY, L ;
SAAH, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 138 (04) :256-265
[6]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[7]  
BOSHOFF C, 1995, LANCET, V345, P1043
[8]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[9]   INFECTIONS WITH HERPES-SIMPLEX VIRUSES .1. [J].
COREY, L ;
SPEAR, PG .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (11) :686-691
[10]   INFECTIONS WITH HERPES-SIMPLEX VIRUSES .2. [J].
COREY, L ;
SPEAR, PG .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (12) :749-757